IOL Chemicals and Pharmaceuticals Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20

Sources of funds

Owner's fund

Equity share capital

58.71

58.71

58.71

58.71

56.89

Share application money

-

-

-

-

3.93

Preference share capital

-

-

-

-

-

Reserves & surplus

1,552.62

1,447.84

1,331.56

1,201.72

752.72

Loan funds

Secured loans

32.76

79.63

42.75

-

55.92

Unsecured loans

-

-

-

-

-

Total

1,644.09

1,586.18

1,433.02

1,260.43

869.46

Uses of funds

Fixed assets

Gross block

1,233.49

993.75

760.73

675.71

594.82

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

300.80

242.44

200.09

163.35

125.78

Net block

932.69

751.31

560.64

512.36

469.04

Capital work-in-progress

100.87

89.64

105.20

48.27

19.19

Investments

20.59

20.27

2.47

1.22

0.05

Net current assets

Current assets, loans & advances

1,189.82

1,159.39

1,291.98

1,048.24

687.28

Less : current liabilities & provisions

599.88

434.43

527.27

349.66

306.10

Total net current assets

589.94

724.96

764.71

698.58

381.18

Miscellaneous expenses not written

-

-

-

-

-

Total

1,644.09

1,586.18

1,433.02

1,260.43

869.46

Notes:

Book value of unquoted investments

20.59

20.27

2.37

1.22

-

Market value of quoted investments

-

-

-

-

0.05

Contingent liabilities

87.59

66.41

100.21

72.48

49.95

Number of equity sharesoutstanding (Lacs)

587.06

587.06

587.06

587.06

568.88